Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. (Q34617892)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. |
scientific article |
Statements
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer (English)
Donald S Kaufman
Hang Lee
Francis J McGovern
Mary Anne Fallon
Joel S Finkelstein
Matthew R Smith
1 March 2007
1 reference
1 reference
1 reference
1 reference